+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Group I intron renders differential susceptibility of Candida albicans to Bleomycin



Group I intron renders differential susceptibility of Candida albicans to Bleomycin



Molecular Biology Reports 34(1): 11-17



The alarming increase in drug resistance gained by fungal pathogens has raised an urgent need to develop drugs against novel targets. Candida albicans, an opportunistic fungal pathogen, harbors in its 25S rRNA gene, a self-splicing Group I intron, which can act as a selective drug target. We report that Bleomycin selectively inhibits the self-splicing of Group I intron of C. albicans at IC(50) = 1.2 microM, leading to accumulation of precursor RNA as evinced by Reverse Transcriptase PCR. Drug susceptibility assays including MIC determination, growth curve analysis and disc diffusion assays indicate a strong susceptibility of the intron-containing strain (4-1) than the intronless strain (62-1). These results on the preferential targeting of Group I intron of C. albicans by Bleomycin might form a basis for design of small molecules that inhibit self-splicing of RNA as a antimicrobial tool against life-threatening microorganisms.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012977489

Download citation: RISBibTeXText

PMID: 17115251

DOI: 10.1007/s11033-006-9002-1


Related references

Group I intron as therapeutic target A preliminary study on the growth inhibition of Candida albicans by bleomycin. Journal of Biomolecular Structure and Dynamics 20(6): 871, 2003

A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron. Gene (amsterdam). 180(1-2): 189-196, 1996

Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron. Journal of Clinical Microbiology 39(12): 4309-4315, 2001

Folding of the group I intron ribozyme from the 26S rRNA gene of Candida albicans. Nucleic Acids Research 29(12): 2644-2653, 2001

Recognition elements for 5' exon substrate binding to the Candida albicans group I intron. Biochemistry Washington 40(21): 6507-6519, 2001

Designing therapeutics based on molecular recognition of a Candida albicans group I intron. Abstracts of Papers American Chemical Society 220(Part 1): MEDI 103, 2000

Oligonucleotide directed misfolding of RNA inhibits Candida albicans group I intron splicing. Proceedings of the National Academy of Sciences of the United States of America 99(17): 11091-6, 2002

The susceptibility of Candida albicans strains to selected anticancer drugs and flucytosine, relevance of the presence of self-splicing intron in 25S rDNA. Journal de Mycologie Medicale 29(1): 39-43, 2019

Frequency and distribution of group I intron genotypes of Candida albicans colonising critically ill patients. British Journal of Biomedical Science 62(1): 24-27, 2005

Expression of a reporter gene interrupted by the Candida albicans group I intron is inhibited by base analogs. Nucleic Acids Research 25(2): 431-437, 1997

Binding enhancement by tertiary interactions and suicide inhibition of a Candida albicans group I intron by phosphoramidate and 2'-O-methyl hexanucleotides. Biochemistry 40(21): 6520-6526, 2001

Tetrahymena thermophila and Candida albicans group I intron-derived ribozymes can catalyze the trans-excision-splicing reaction. Nucleic Acids Research 36(16): 5281-5289, 2008

Dimorphism phenomenon and metabolism in Candida albicans. I. Effect of oxygen tension on the mycelium formation in Candida group; II. Aerobic carbohydrate dissimilation by yeast and mycelial forms of Candida albicans; III. Respiratory metabolism of amino acids by yeast and mycelial forms of Candida albicans. Japanese Jour Bact 14(10-11-12): 861-867, 909-912, 1009-1012, 1959

Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates. Cornea 34(5): 576-579, 2015

Molecular recognition by the Candida albicans group I intron: tertiary interactions with an imino G A pair facilitate binding of the 5' exon and lower the KM for guanosine. Biochemistry (American Chemical Society) 41(25): 13-19, 2002